INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $463,000 | +20.3% | 36,606 | 0.0% | 0.01% | +11.1% |
| Q1 2017 | $385,000 | +14.2% | 36,606 | 0.0% | 0.01% | +12.5% |
| Q4 2016 | $337,000 | -22.0% | 36,606 | 0.0% | 0.01% | -20.0% |
| Q3 2016 | $432,000 | -64.4% | 36,606 | -13.7% | 0.01% | -65.5% |
| Q4 2015 | $1,215,000 | -16.4% | 42,427 | -17.0% | 0.03% | -21.6% |
| Q3 2015 | $1,454,000 | -60.8% | 51,097 | -50.5% | 0.04% | -53.8% |
| Q2 2015 | $3,706,000 | +3.7% | 103,168 | +67.8% | 0.08% | +14.3% |
| Q1 2015 | $3,574,000 | +193.7% | 61,479 | +113.0% | 0.07% | +218.2% |
| Q4 2014 | $1,217,000 | +8.7% | 28,869 | 0.0% | 0.02% | +15.8% |
| Q3 2014 | $1,120,000 | +104.0% | 28,869 | +64.3% | 0.02% | +111.1% |
| Q2 2014 | $549,000 | -24.6% | 17,569 | -0.0% | 0.01% | -25.0% |
| Q1 2014 | $728,000 | +4.3% | 17,570 | -2.5% | 0.01% | 0.0% |
| Q4 2013 | $698,000 | -56.5% | 18,023 | -60.7% | 0.01% | -58.6% |
| Q3 2013 | $1,605,000 | – | 45,884 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
| Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
| Front Row Advisors LLC | 60 | $0 | 0.00% |
| Executive Wealth Management, LLC | 20 | $0 | 0.00% |
| BARCLAYS PLC | 1,300 | $0 | 0.00% |
| BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
| Vectors Research Management, LLC | 505 | $0 | 0.00% |